4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amino]ethyl](carboxymethyl)amino]methyl]-4-hydroxyphenyl]-5,13,20-trioxo-, (3S,7S)-
4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amino]ethyl](carboxymethyl)amino]methyl]-4-hydroxyphenyl]-5,13,20-trioxo-, (3S,7S)- Basic information
- Product Name:
- 4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amino]ethyl](carboxymethyl)amino]methyl]-4-hydroxyphenyl]-5,13,20-trioxo-, (3S,7S)-
- Synonyms:
-
- 4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amino]ethyl](carboxymethyl)amino]methyl]-4-hydroxyphenyl]-5,13,20-trioxo-, (3S,7S)-
- PSMA11
- 4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxypheny
- PSMA-11 trifluoroacetate
- PSMA-HBED-CC
- DKFZ-PSMA-11
- HBED-CC-PSMA(1366302-52-4)
- (3S,7S)-22-(3-(((2-((5-(2-carboxyethyl)-2-hydroxybenzyl)(carboxymethyl)amino)ethyl)(carboxymethyl)amino)methyl)-4-hydroxyphenyl)-5,13,20-trioxo-4,6,12,19-tetraazadocosane-1,3,7-tricarboxylic acid
- CAS:
- 1366302-52-4
- MF:
- C44H62N6O17
- MW:
- 946.99308
- EINECS:
- 246-639-0
- Mol File:
- 1366302-52-4.mol
More
Less
4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amino]ethyl](carboxymethyl)amino]methyl]-4-hydroxyphenyl]-5,13,20-trioxo-, (3S,7S)- Chemical Properties
- storage temp.
- -20°C, protect from light
- solubility
- To be determined:100.0(Max Conc. mg/mL);105.6(Max Conc. mM)
- form
- Solid
- color
- White to off-white
More
Less
4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amino]ethyl](carboxymethyl)amino]methyl]-4-hydroxyphenyl]-5,13,20-trioxo-, (3S,7S)- Usage And Synthesis
Uses
The prostate-specific membrane antigen (PSMA) has received increased consideration during the past few years as an excellent target for both imaging and therapy of prostate cancer. ?After many years of outstanding preclin.
4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amino]ethyl](carboxymethyl)amino]methyl]-4-hydroxyphenyl]-5,13,20-trioxo-, (3S,7S)-Supplier
Hangzhou Sinoda Pharmaceutical Technology Co. LTD Gold
- Tel
- 0571-87213919 17306812703
- 3007955328@qq.com
Hangzhou Baige Pharmaceutical Technology Co. , Ltd. Gold
- Tel
- 0571-85350119 15888826472
- 15888826472@163.com
Nanchang Tianzhen Biotechnology Co., Ltd Gold
- Tel
- 13173652190
- pomy@tanzhenbio.com
Hangzhou Beiputai Biopharmaceutical Co., Ltd Gold
- Tel
- 0571-85350119 13305819357
- bptsales@163.com
YangZhou Ruihong Biotech Co., Ltd.
- Tel
- 015380367604 15380367604